Will genetic analysis of cannabis aid big pharma in making expensive new products? Or hold down prices by protecting generic strains.
Genetic analysis of varying cannabis strains may aid in the development of narrowly targeted pharmaceutical products. But using the same tool to protect generic strains could help hold prices down.
There’s more on the subject on the North Bay Report webpage at KRCB dot org/news. Hear this story on demand with our free KRCB mobile app. You can also find this and past stories on our new North Bay Report Facebook page. Comment, share and give us a like there. Follow the North Bay Report on Twitter @KRCBNews.
Podcast: Play in new window | Download
Subscribe: Google Podcasts | RSS